1/22/2008 – Vapotherm, the global leader in High Flow Oxygen Therapy products, announced today that U.S. patent rights have been validated for an apparatus used in the delivery tube technology for
respiratory tract therapy. Reinforcing Vapotherm’s principal role in the industry, the U.S. Patent No. 7,314,046 B2 has been granted through 2022 and provides Vapotherm the right to prevent or exclude other companies from making, using, selling, or offering to sell or import the invention.
The triple lumen design is the vital component for Vapotherm products as it helps deliver humidified air to the respiratory tract of patients. Used throughout all Vapotherm products, including the 2000i and the recently introduced Precision Flow™, the apparatus allows Vapotherm to maintain the conditioned breathing gases to the patient and thus aid with respiratory tract therapy and treatment...
Vapotherm's Press Release-
